Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

April W Armstrong

Showing results (301-310 of 522) with videos related to

Pageof 53
Sort By:
American Journal of Clinical Dermatology|October 26, 2021
Expert Perspectives on Key Parameters that Impact Interpretation of Randomized Clinical Trials in Moderate-to-Severe Atopic DermatitisJonathan I Silverberg, Eric L Simpson, April W Armstrong, et al.
Journal of the American Academy of Dermatology|October 22, 2023
Safety and efficacy of eblasakimab, an interleukin 13 receptor α1 monoclonal antibody, in adults with moderate-to-severe atopic dermatitis: A phase 1b, multiple-ascending dose studyKaren A Veverka, Steven T G Thng, Jonathan I Silverberg, et al.
Plos One|January 26, 2019
Real-world utilization patterns of systemic immunosuppressants among US adult patients with atopic dermatitisApril W Armstrong, Ahong Huang, Li Wang, et al.
Dermatology Online Journal|June 13, 2021
Mental health outcomes in White patients versus patients with skin of color with psoriasisAlison H Kohn, Sarah P Pourali, Yasmin Gutierrez, et al.
The Journal of Dermatological Treatment|August 19, 2017
Using qualitative methods to understand factors contributing to patient satisfaction among dermatology patients: a systematic reviewCaitlin Gibbons, Sanminder Singh, Brittany Gibbons, et al.
The Journal of Dermatological Treatment|August 20, 2016
Assessing the overall benefit of a medication: cumulative benefit of secukinumab over time in patients with moderate-to-severe plaque psoriasisApril W Armstrong, Steven R Feldman, Neil J Korman, et al.
Journal of Drugs in Dermatology : JDD|March 17, 2017
The International Dermatology Outcome Measures (IDEOM) Initiative: A Review and UpdateScott A Elman, Joseph F Merola, April W Armstrong, et al.
Journal of the American Academy of Dermatology|July 18, 2021
Opiate use in dermatology: A population-based study using the National Ambulatory Medical Care Survey in the United StatesSarah P Pourali, Alison H Kucharik, Yasmin Gutierrez, et al.
JAMA Dermatology|June 30, 2021
Psoriasis Prevalence in Adults in the United StatesApril W Armstrong, Manan D Mehta, Clayton W Schupp, et al.
The Journal of Rheumatology|August 5, 2025
Report of the IDEOM Meeting Adjacent to the GRAPPA 2024 Annual MeetingSarah Romanelli, Beth Childs, Vibeke Strand, et al.
Pageof 53

Showing results (301-310 of 522) with videos related to

Sort By:
Pageof 53
American Journal of Clinical Dermatology|October 26, 2021
Expert Perspectives on Key Parameters that Impact Interpretation of Randomized Clinical Trials in Moderate-to-Severe Atopic DermatitisJonathan I Silverberg, Eric L Simpson, April W Armstrong, et al.
Journal of the American Academy of Dermatology|October 22, 2023
Safety and efficacy of eblasakimab, an interleukin 13 receptor α1 monoclonal antibody, in adults with moderate-to-severe atopic dermatitis: A phase 1b, multiple-ascending dose studyKaren A Veverka, Steven T G Thng, Jonathan I Silverberg, et al.
Plos One|January 26, 2019
Real-world utilization patterns of systemic immunosuppressants among US adult patients with atopic dermatitisApril W Armstrong, Ahong Huang, Li Wang, et al.
Dermatology Online Journal|June 13, 2021
Mental health outcomes in White patients versus patients with skin of color with psoriasisAlison H Kohn, Sarah P Pourali, Yasmin Gutierrez, et al.
The Journal of Dermatological Treatment|August 19, 2017
Using qualitative methods to understand factors contributing to patient satisfaction among dermatology patients: a systematic reviewCaitlin Gibbons, Sanminder Singh, Brittany Gibbons, et al.
The Journal of Dermatological Treatment|August 20, 2016
Assessing the overall benefit of a medication: cumulative benefit of secukinumab over time in patients with moderate-to-severe plaque psoriasisApril W Armstrong, Steven R Feldman, Neil J Korman, et al.
Journal of Drugs in Dermatology : JDD|March 17, 2017
The International Dermatology Outcome Measures (IDEOM) Initiative: A Review and UpdateScott A Elman, Joseph F Merola, April W Armstrong, et al.
Journal of the American Academy of Dermatology|July 18, 2021
Opiate use in dermatology: A population-based study using the National Ambulatory Medical Care Survey in the United StatesSarah P Pourali, Alison H Kucharik, Yasmin Gutierrez, et al.
JAMA Dermatology|June 30, 2021
Psoriasis Prevalence in Adults in the United StatesApril W Armstrong, Manan D Mehta, Clayton W Schupp, et al.
The Journal of Rheumatology|August 5, 2025
Report of the IDEOM Meeting Adjacent to the GRAPPA 2024 Annual MeetingSarah Romanelli, Beth Childs, Vibeke Strand, et al.
Pageof 53